Cancel
Bob Valamehr, Ph.D.
Chief Research & Development Officer
@
Fate Therapeutics
554.k49yw092.3x.w@w78g78ng8k74jg18.k24
Sign up to see email
Known information
- Previously held the positions of Chief Development Officer and Vice President of Cancer Immunotherapy at Fate Therapeutics
- Played key scientific roles at Amgen, the Center for Cell Control, and the Broad Stem Cell Research Center
- Developed novel methods to control pluripotency, modulate stem cell fate including hematopoiesis, and better understand cellular signaling pathways associated with aberrant cellular function
- Co-authored numerous studies and patents related to stem cell biology, oncology, and materials science
- Received his Ph.D. from the Department of Molecular and Medical Pharmacology at UCLA
- Earned an M.B.A. from Pepperdine University
- Holds a B.S. from the Department of Chemistry and Biochemistry at UCLA
About Fate Therapeutics
Fate Therapeutics operates advanced manufacturing facilities in San Diego for iPSC-derived cell therapies and collaborates with several institutions to develop cancer treatments.
Report inaccurate information
